NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/31/2026
Back to search
Official data from USPTO
MOONWALK BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
MOONWALK BIOSCIENCES
ST13
US500000098977812Class
42
Filing
98977812
Registration
8198362
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
03/31/2026
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
10/02/2023
Registration date
03/31/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2026
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/01/2022
First use in commerce
01/01/2023
Drawing code
4
Owner type
03
Owner location
South San Francisco, CA, US
Examiner
SOUDERS, MICHAEL J
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
M. B. (pessoa física)
Representatives
Michael J. Allan STEPTOE LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the field of pharmaceuticalstherapeuticsbiotechnology; Conducting research and clinical trials for others relating to pharmaceuticals in the fields of age-relatedautoimmunecardiometaboliccardiovasculardermatologicalendocrineepigeneticgastrointestinalgenetichematologicalhemoglobinopathyimmunologicalinfectiouslivermetabolicmuscular dystrophyneurodegenerativeneuropsychiatriconcologicalophthalmologicalpediatricpsychiatricpulmonaryrenalreproductiverespiratoryskeletal diseases; Conducting research and clinical trials for others relating to veterinary pharmaceuticals in the fields of age-relatedautoimmunecardiometaboliccardiovasculardermatologicalendocrineepigeneticgastrointestinalgenetichematologicalhemoglobinopathyimmunologicalinfectiouslivermetabolicmuscular dystrophyneurodegenerativeneuropsychiatriconcologicalophthalmologicalpsychiatricpulmonaryrenalreproductiverespiratoryskeletal diseases
Publications
History of USPTO decisions and trademark events.
37 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/31/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/10/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/10/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/09/2026
DPCC
DIVISIONAL PROCESSING COMPLETE
03/06/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/06/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/18/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/17/2026
IUAF
USE AMENDMENT FILED
07/11/2025
DRRR
DIVISIONAL REQUEST RECEIVED
07/11/2025
EISU
TEAS STATEMENT OF USE RECEIVED
07/11/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
07/11/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2025
PUBO
PUBLISHED FOR OPPOSITION
01/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
12/12/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/12/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
12/12/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/30/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/27/2024
GNFR
FINAL REFUSAL E-MAILED
08/27/2024
CNFR
FINAL REFUSAL WRITTEN
08/27/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/19/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/19/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/19/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/23/2024
GNRT
NON-FINAL ACTION E-MAILED
05/23/2024
CNRT
NON-FINAL ACTION WRITTEN
05/23/2024
DOCK
ASSIGNED TO EXAMINER
05/22/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/12/2023
NWAP
NEW APPLICATION ENTERED
10/05/2023
Continuous trademark protection
Get notified about every new filing that threatens MOONWALK BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.